Explore our featured news items here. Subscribe to stay informed of all information shared and published by DHC.
Sponsor appreciation:
You’re invited to explore and join Physician Factor, a knowledge exchange network is a dedicated portal for physicians seeking opportunities to contribute their expertise and input in exchange for compensation and supplemental income.
You can search articles using your own keywords or the following tags: Type 1 | Type 2 | Research | Drugs and Therapies
NYITCOM Physician: Diabetes Patients Should Heed FDA Warning
In late February, the Food and Drug Administration (FDA) warned diabetes patients not to use smartwatches or smart rings to measure their blood glucose levels. Following the FDA’s alert, obesity medicine expert Eleanor Yusupov, D.O., assistant professor at the College of Osteopathic Medicine, shares valuable insight for these patients.
‘Bionic Pancreas’ Tested in San Antonio Adapts to Type 1 Diabetes Patients’ Needs
Fifteen-year-old Mia Campos is living with Type 1 diabetes and can now enjoy everyday activities without any limitations thanks to her new "bionic pancreas." Campos's new “bionic pancreas” is a wearable, electronic device that replaces the role of her pancreas and adapts to the needs of her endocrine system over time. The iLet Insulin system was developed by Massachusetts-based Beta Bionics and is one of many new advances in diabetes management technology which are improving ways to automate insulin delivery.
Diabetes and Liver Cancer — Stanford Medicine Study Suggests New Screening Guidelines
A Stanford Medicine study identifies an easily measured biophysical property that can identify Type 2 diabetics at increased risk for liver cancer who don’t meet current screening guidelines. Researchers at Stanford University have shown that another biophysical characteristic known as viscoelasticity — think of how stretching a ball of Silly Putty or a clump of bread dough is met at first with resistance, and then with release — is even more tightly correlated with liver cancer than stiffness, particularly in people with Type 2 diabetes.
Virginia Tech Researchers Awarded Nearly $2 Million To Explore New Treatment for Type 2 Diabetes and Obesity
A team of Virginia Tech researchers was awarded nearly $2 million from the National Institute of Diabetes and Digestive and Kidney Disease, part of the National Institutes of Health, to explore novel approaches for treating Type 2 diabetes and obesity. The team of researchers, led by principal investigator Dongmin Liu, will study the impact of a derivative of secoiridoid, a natural compound found in certain plants like olives, on blood sugar control and obesity, which are often precursors to Type 2 diabetes.
Transforming Diabetes Care with Precision Medicine
“Precision medicine” involves customizing interventions to the unique genetic and molecular makeup of individual patients rather than relying on symptoms or broad categories. This approach, long associated with cancer treatment, is becoming increasingly critical for diabetes prevention and care. Precise diagnosis and disease characterization affect not only treatment choices but life planning, other health considerations, and even family members’ well-being. It means providing the right diagnosis, best care and insights into outcomes for all people with diabetes.
Repurposed Drug Offers New Potential for Managing Type 1 Diabetes
A recent study led by Indiana University School of Medicine in collaboration with the University of Chicago Medicine presents exciting future possibilities for the management of type 1 diabetes and the potential reduction of insulin dependency. The researchers’ findings, published in Cell Reports Medicine, suggest repurposing of the drug α-difluoromethylornithine (DFMO) may open doors to innovative therapies in the future.
What Is Insulin Resistance and How Do You Know if You Have It?
According to the Centers for Disease Control and Prevention, 37.3 million adults have diabetes and 96 million — or more than one-third of Americans — have pre-diabetes. Because insulin resistance is a precursor to both, researchers estimate the number of people with insulin resistance is much higher.. “Most people don’t even know that they have it,” said Dr. Mary Vouyiouklis Kellis, an endocrinologist at Cleveland Clinic.
An Implantable Device Could Enable Injection-Free Control of Diabetes
The implantable device contains encapsulated cells that produce insulin, plus a tiny oxygen-producing factory that keeps the cells healthy. It could be enable injection-free control of diabetes.
Storing Fat At The Waist May NOT Up Diabetes Risk, Surprise Findings Indicate
Conventional wisdom holds that storing fat around your belly puts you at increased risk for type 2 diabetes. But unexpected new findings suggest that, for some people, conventional wisdom may be wrong.
Proteins Predict Significant Step Toward Development of Diabetes
Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear. In a paper published online on June 29 in Cell Reports Medicine, researchers at the Department of Energy’s Pacific Northwest National Laboratory and their colleagues identify a set of altered proteins that predict a condition known as islet autoimmunity, a precursor for everyone who will ultimately develop Type 1 diabetes.
Scientists Target Human Stomach Cells for Diabetes Therapy
Stem cells from the human stomach can be converted into cells that secrete insulin in response to rising blood sugar levels, offering a promising approach to treating diabetes, according to a preclinical study from researchers at Weill Cornell Medicine.
Too Much Insulin Can Be As Dangerous As Too Little
One hundred years of research have greatly advanced medical and biochemical understanding of how insulin works and what happens when it is lacking, but the reverse, how potentially fatal insulin hyper-responsiveness is prevented, has remained a persistent mystery. In a new study, published in the April 20, 2023 online edition of Cell Metabolism, a team of scientists at the University of California San Diego School of Medicine, with colleagues elsewhere, describe a key player in the defense mechanism that safeguards us against excessive insulin in the body.
Study Links Poor Diet to 14 Million Cases of Type 2 Diabetes Globally
Researchers from the Friedman School of Nutrition Science and Policy estimate 7 out of 10 cases of type 2 diabetes worldwide in 2018 linked to food choices.
Study Unlocks Potential Breakthrough In Type 1 Diabetes Treatment
For the well over 700 million people around the globe living with type 1 diabetes, getting a host immune system to tolerate the presence of implanted insulin-secreting cells could be life-changing. Rice University bioengineer Omid Veiseh and collaborators identified new biomaterial formulations that could help turn the page on type 1 diabetes treatment, opening the door to a more sustainable, long-term, self-regulating way to handle the disease. To do so, they developed a new screening technique that involves tagging each biomaterial formulation in a library of hundreds with a unique “barcode” before implanting them in live subjects.
Different Ways to Provide Better Health Care for Diabetic Patients
Health care providers play a crucial role in helping their patients prevent or delay type 2 diabetes and manage all types of diabetes. The following resources can support your efforts to screen, test, and refer people to type 2 diabetes prevention and diabetes management programs and services.
New Third Edition: The Mayo Clinic Diet
For endocrinologists seeking methods to help patients with diabetes to lose weight, many evaluate The Mayo Clinic Diet, which is based on the concept of energy density. Jason Ewoldt, M.S., RDN, LD, with Clinical Nutrition at Mayo Clinic's campus in Rochester, Minnesota, explains, "By consuming generous amounts of low energy dense fresh or frozen vegetables and fruits, people can achieve satiety at a lower calorie intake and better manage weight. Choosing more limited amounts of healthier choices in the other food groups can improve health in addition to help manage weight."
The Standards of Care in Diabetes for 2023
Dr. Robert Gabbay, Chief Scientific and Medical Officer, American Diabetes Association, discusses the standard care given to diabetics in 2023. Watch video to learn more.
Can Lab-Grown Beta Cells Revolutionize Diabetes Care?
Since the 1970s, clinicians have known that people with type 1 diabetes can be treated by transplanting pancreatic islets – clusters of insulin-producing “beta cells” – from a healthy organ donor. The procedure, however, is limited by a shortage of donors. The renowned diabetes researcher Douglas Melton, PhD, at Harvard University, leads a group that developed a way to increase islet supplies by generating pancreatic beta cells in the lab from stem cells. Today, researchers and scientists refine this process by coaxing stem cells to reliably develop into functional beta cells that can be transplanted into patients to produce insulin.
New Study Identifies Connection Between Diabetes Medications, Multiple Sclerosis
A new study found that anti-hyperglycemic medications used to treat Type 2 diabetes resulted in an increased risk of multiple sclerosis for people older than 45, particularly among women.